Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg

Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg
B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP……………………135mg
Valproic acid IP…………………………….58mg
(Both together corresponds to sodium valproate IP 150mg)
Excipients………………………………………q.s.
Colour: Erythrosine

B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………….200mg
Valproic acid IP……………………………….87mg
(Both together corresponds to sodium valproate IP 250mg)
Excipients……………………………………..q.s.
Colour: Ponceau 4 R

C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………333mg
Valproic acid IP…………………………145mg
(Both together corresponds to sodium valproate IP 500mg)
Excipients…………………………………..q.s.
Colour: Quinoline yellow SS

D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………..499mg
Valproic acid IP……………………………217mg
(Both together corresponds to sodium valproate IP 750mg)
Excipients………………………………………q.s.
Colour: Lake brilliant blue

THERAPEUTIC INDICATIONS:

Sodium Valproate + Valproic Acid is used in the treatment of epilepsy.

CAUTION &  WARNING:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.

WARNING : NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.

STORAGE & DOSAGE:

Storage: Store below 30 °C.
Protect from Light.
Dosage: As directed by the Physician.

Introduction to Sodium Valproate & Valproic Acid Controlled Release Tablets 135mg+58mg

Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg are a highly effective combination therapy widely used for epilepsy, bipolar disorder, and migraine prevention. This formulation works by enhancing gamma-aminobutyric acid (GABA) activity in the brain, stabilizing neural activity, and preventing seizures or extreme mood swings.

The controlled-release (CR) technology ensures steady drug levels in the bloodstream for 12–24 hours, improving patient compliance and reducing the frequency of dosing. Due to the growing prevalence of neurological disorders and epilepsy worldwide, the demand for high-quality, reliable Sodium Valproate & Valproic Acid CR tablets is increasing steadily.

Taj Pharma, a well-known manufacturer, exporter, and supplier in India, ensures each batch meets international quality standards, regulatory compliance, and consistency in efficacy and safety.

Trusted Manufacturer of Sodium Valproate & Valproic Acid Controlled Release Tablets 135mg+58mg

Taj Pharma Ltd. has established itself as a leading pharmaceutical company in India, specializing in anticonvulsants and psychiatric medications. The company manufactures Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg under strict WHO-GMP and EU-GMP standards, ensuring high purity, safety, and bioequivalence.

With advanced production facilities in Vapi, Gujarat, Taj Pharma employs automated blending, compression, coating, and packaging systems, coupled with stringent in-process and post-production quality checks. The company also provides custom packaging and labeling for global importers, distributors, and PCD franchise partners.

Therapeutic Overview of Sodium Valproate & Valproic Acid Tablets

Indications:

• Epilepsy: Effective for generalized and partial seizures, reducing frequency and intensity.

• Bipolar Disorder: Stabilizes mood and prevents manic episodes.

• Migraine Prevention: Reduces the frequency of migraine attacks by calming overactive neurons.

Mechanism of Action:
Sodium Valproate and Valproic Acid increase GABA levels, an inhibitory neurotransmitter that reduces excessive neuronal firing, stabilizing brain activity and preventing seizures and mood swings.

Common Side Effects:

• Weight gain

• Drowsiness or fatigue

• Tremors

• Liver injury (rare)

• Dizziness and vertigo

• Paresthesia (tingling or prickling sensation)

• Hypersensitivity reactions

• Anemia (low red blood cell count)

• Deafness (rare)

• Urinary incontinence

• Hyponatremia (low sodium in blood)

• Pain during menstruation

Taj Pharma ensures high-quality production to minimize side effects and maximize patient safety.

Detailed Information for Importers, Exporters & Buyers

Regulatory Documentation Provided

Taj Pharma provides complete regulatory support for international buyers:

• WHO-GMP Certificate

• EU-GMP Certificate

• Certificate of Pharmaceutical Product (COPP)

• Certificate of Analysis (CoA)

• Free Sale Certificate (FSC)

• Stability Data and Batch Records

• CTD Dossier for regulatory submissions

Custom Packaging & Labeling

• Alu-Alu blister packs and HDPE bottles

• Multi-language labels for international markets (English, French, Spanish, Arabic)

• Tamper-evident and serialized packaging

• Country-specific labeling for compliance

Shelf-Life, Storage & Dosage Form

• Dosage Form: Controlled Release Tablet

• Strength: 135mg + 58mg

• Shelf Life: 24–36 months

• Storage: Store below 30°C, protect from moisture and sunlight

Export Certifications

• WHO-GMP certified production facilities

• EU-GMP approved

• ISO 9001:2015 Quality Management System

• GLP-compliant laboratories

• CTD dossiers for regulatory submission

Target Countries & Export Markets

Taj Pharma exports Sodium Valproate & Valproic Acid CR tablets to more than 80 countries, including:

• Asia: Vietnam, Thailand, Philippines, Sri Lanka, Bangladesh

• Africa: Nigeria, Kenya, Ghana, South Africa, Ethiopia

• Middle East: UAE, Saudi Arabia, Iraq, Jordan, Yemen

• Europe: Ukraine, Poland, Romania, Czech Republic, Belarus

• Latin America: Chile, Peru, Guatemala, Honduras, Bolivia

Why is the Most Trusted Manufacturer & Supplier

1. State-of-the-Art Manufacturing Facilities

Taj Pharma’s manufacturing units in Vapi, Gujarat, and Mumbai, Maharashtra are equipped with modern automated machinery, clean rooms, and advanced quality testing labs, ensuring consistent production of high-quality Sodium Valproate & Valproic Acid CR tablets.

2. Affordable Pricing & Quality Assurance

By vertically integrating raw material sourcing and production, Taj Pharma offers competitive pricing without compromising on quality, making it a preferred partner for global distributors and hospitals.

3. Global Supply Chain & Presence

With an extensive logistics network, Taj Pharma ensures timely delivery, customs clearance support, and regulatory dossier management for international clients.

4. Top 20 Export Countries

India | UAE | Saudi Arabia | Oman | Kenya | Nigeria | South Africa | Ghana | Vietnam | Myanmar | Philippines | UK | Germany | France | Brazil | Chile | Peru | Colombia | Mexico | USA

Technical Product Specification Table:  

Call to Action for Buyers & Distributors

If you are an importer, distributor, or hospital procurement professional looking for a trusted Sodium Valproate & Valproic acid CR tablet manufacturer and supplier in India, Taj Pharma is your ideal partner.

📞 Contact Taj Pharma Ltd.
Email: info@tajpharma.com
Website: www.tajpharma.in
Address: Taj Pharma Ltd., Vapi, Gujarat, India

Taj Pharma provides competitive quotations, regulatory documentation, and customized packaging for international buyers.

Top 20 FAQs  

1. What is the use of this combination tablet?
   Treats epilepsy, bipolar disorder, and migraine prevention.

2. Is Taj Pharma WHO-GMP certified?
   Yes, all production is WHO-GMP and EU-GMP certified.

3. What are the common side effects?
   Weight gain, drowsiness, tremors, liver injury, dizziness, and paresthesia.

4. How should these tablets be stored?
   Store below 30°C, away from light and moisture.

5. Can Taj Pharma provide export documentation?
   Yes, including COPP, CoA, CTD dossiers, and FSC.

6. What is the shelf life?
   24–36 months.

7. Can it be used during pregnancy?
   Only under strict medical supervision.

8. Does Taj Pharma offer private labeling?
   Yes, custom branding and packaging is available.

9. What is the recommended dosage?
   As prescribed by a physician.

10. Does it interact with other medications?
    Yes, consult a healthcare professional for drug interactions.

11. Are there PCD franchise opportunities?
    Yes, Taj Pharma offers PAN India franchise partnerships.

12. What is the minimum export order quantity?
    Contact Taj Pharma for specific market requirements.

13. Is it safe for long-term use?
    Yes, with regular monitoring by a physician.

14. How quickly does it act?
    Controlled-release formulation ensures steady levels over 12–24 hours.

15. Can it be combined with other antiepileptics?
    Yes, under medical supervision.

16. What packaging options are available?
    Alu-Alu blister packs, HDPE bottles, and bulk packs.

17. Does Taj Pharma export worldwide?
    Yes, to over 80 countries.

18. Which pharmacopoeial standards are followed?
    IP, BP, and USP depending on the export market.

19. Is Taj Pharma a reliable supplier for hospitals?
    Yes, bulk supply with regulatory support is provided.

20. How can international buyers contact Taj Pharma?
    Email info@tajpharma.com or visit www.tajpharma.in